LHX4突变在417例无亲缘关系患者垂体功能缺陷中的贡献
在417例无亲缘关系的单纯性生长激素缺乏或合并垂体激素缺乏伴垂体后叶异位和/或蝶鞍异常的患者中筛查LHX4突变,检出7种杂合变异,其中6种为致病突变;LHX4突变表现为表现度可变、多数外显不全,在该队列中对相关垂体缺陷的贡献约为1.4%。
要点
- 在417例无亲缘关系患者中筛查LHX4,检出7种杂合变异,其中6种为致病突变。
- LHX4突变表现为表现度可变,7种变异中5种外显不全。
- LHX4突变对伴垂体后叶异位和/或蝶鞍缺陷的垂体功能缺陷贡献约1.4%。
核心结论
- 本研究在迄今筛查LHX4突变的最大队列中进行,描述了6种导致先天性垂体功能减退的致病突变。
- LHX4突变表现为表现度可变,多数外显不全;在417例先证者中,其对伴垂体后叶异位和/或蝶鞍缺陷的垂体功能缺陷的贡献约为1.4%。
研究设计与样本
- 研究纳入417例无亲缘关系的患者,均为单纯性生长激素缺乏或合并垂体激素缺乏,并伴垂体后叶异位和/或蝶鞍异常。
- 采用Sanger测序筛查LHX4突变,并进行体外研究评估所检出变异的功能后果。
主要发现
- 检出7种杂合变异:p.(Tyr131*)、p.(Arg48Thrfs*104)、c.606+1G>T、p.Arg65Val、p.Thr163Pro、p.Arg221Gln和p.Arg235Gln,均与表现度可变相关,其中5种与不完全外显相关。
- p.(Tyr131*)、p.(Arg48Thrfs*104)、p.Ala65Val、p.Thr163Pro和p.Arg221Gln变异无法反式激活POU1F1和GH启动子。
- 根据反式激活、亚细胞定位和蛋白-蛋白相互作用研究,p.Arg235Gln可能是一种罕见多态性。
- 免疫共沉淀研究提示LHX3是LHX4的潜在蛋白伙伴。
- 对LIM缺陷重组LHX4蛋白的功能研究显示,LIM1和LIM2结构域并非冗余。
关键数值与推荐
- 7种杂合变异中5种与不完全外显相关,均与表现度可变相关。
- p.(Tyr131*)、p.(Arg48Thrfs*104)、p.Ala65Val、p.Thr163Pro和p.Arg221Gln变异无法反式激活POU1F1和GH启动子。
- p.Arg235Gln可能为罕见多态性。
- LHX4突变对伴垂体后叶异位和/或蝶鞍缺陷的垂体功能缺陷的贡献约为1.4%(417例先证者中)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: LHX4 encodes a LIM-homeodomain transcription factor that is implicated in early pituitary development. In humans, only 13 heterozygous LHX4 mutations have been associated with congenital hypopituitarism. OBJECTIVE: The aims of this study were to evaluate the prevalence of LHX4 mutations in patients with hypopituitarism, to define the associated phenotypes, and to characterize the functional impact of the identified variants and the respective role of the 2 LIM domains of LHX4. DESIGN AND PATIENTS: We screened 417 unrelated patients with isolated growth hormone deficiency or combined pituitary hormone deficiency associated with ectopic posterior pituitary and/or sella turcica anomalies for LHX4 mutations (Sanger sequencing). In vitro studies were performed to assess the functional consequences of the identified variants. RESULTS: We identified 7 heterozygous variations, including p.(Tyr131*), p.(Arg48Thrfs*104), c.606+1G>T, p.Arg65Val, p.Thr163Pro, p.Arg221Gln, and p.Arg235Gln), that were associated with variable expressivity; 5 of the 7 were also associated with incomplete penetrance. The p.(Tyr131*), p.(Arg48Thrfs*104), p.Ala65Val, p.Thr163Pro, and p.Arg221Gln LHX4 variants are unable to transactivate the POU1F1 and GH promoters. As suggested by transactivation, subcellular localization, and protein-protein interaction studies, p.Arg235Gln is probably a rare polymorphism. Coimmunoprecipitation studies identified LHX3 as a potential protein partner of LHX4. As revealed by functional studies of LIM-defective recombinant LHX4 proteins, the LIM1 and LIM2 domains are not redundant. CONCLUSION: This study, performed in the largest cohort of patients screened so far for LHX4 mutations, describes 6 disease-causing mutations that are responsible for congenital hypopituitarism. LHX4 mutations were found to be associated with variable expressivity, and most of them with incomplete penetrance; their contribution to pituitary deficits that are associated with an ectopic posterior pituitary and/or a sella turcica defect is ∼1.4% in the 417 probands tested.
引用
- Cohen E, Maghnie M, Collot N, et al. Contribution of LHX4 Mutations to Pituitary Deficits in a Cohort of 417 Unrelated Patients. J Clin Endocrinol Metab. 2017. PMID: 27820671. doi:10.1210/jc.2016-3158
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。